Analysts Set Expectations for CareTrust REIT FY2026 Earnings

CareTrust REIT, Inc. (NYSE:CTRE) – Equities research analysts at Huntington issued their FY2026 EPS estimates for CareTrust REIT in a research note issued to investors on Thursday, November 5th. Huntington analyst R. Stevenson anticipates that the company will post earnings per share of $2.05 for the year. Huntington has an “Outperform” rating and a $44.00 price target on the stock. The consensus estimate for CareTrust REIT’s current full-year earnings is $2.07 per share. Huntington also issued estimates for CareTrust REIT’s Q4 2026 earnings at $0.55 EPS, Q1 2027 earnings at $0.56 EPS, Q2 2027 earnings at $0.57 EPS, Q3 2027 earnings at $0.58 EPS, Q4 2027 earnings at $0.59 EPS, FY2027 earnings at $2.31 EPS, Q1 2028 earnings at $0.59 EPS, Q2 2028 earnings at $0.60 EPS, Q3 2028 earnings at $0.61 EPS and FY2028 earnings at $2.43 EPS.

CareTrust REIT (NYSE:CTRE) last announced its earnings results on Thursday, November 5th. The company reported $0.54 earnings per share for the quarter, beating analysts’ consensus estimates of $0.52 by $0.02. The business had revenue of $176.36 million during the quarter. CareTrust REIT had a net margin of 62.19% and a return on equity of 8.52%.

CTRE has been the subject of a number of other research reports. Wall Street Zen cut CareTrust REIT from a “hold” rating to a “sell” rating in a research report on Saturday. UBS Group lowered their target price on CareTrust REIT from $48.00 to $44.00 and set a “buy” rating on the stock in a report on Tuesday, October 13th. Cantor Fitzgerald raised their target price on CareTrust REIT from $42.00 to $43.00 and gave the stock a “neutral” rating in a research report on Monday, August 10th. Royal Bank Of Canada restated a “sector perform” rating and set a $43.00 price target on shares of CareTrust REIT in a research note on Monday, October 5th. Finally, Raymond James Financial reduced their price target on shares of CareTrust REIT from $45.00 to $42.00 and set an “outperform” rating for the company in a research report on Monday, October 5th. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat, CareTrust REIT presently has an average rating of “Moderate Buy” and an average price target of $43.64.

CareTrust REIT Price Performance

NYSE CTRE opened at $38.81 on Tuesday. The stock has a market capitalization of $9.17 billion, a price-to-earnings ratio of 19.87, a PEG ratio of 1.35 and a beta of 0.77. CareTrust REIT has a 1-year low of $34.74 and a 1-year high of $43.62. The company has a debt-to-equity ratio of 0.27, a current ratio of 0.57 and a quick ratio of 0.57. The business’s fifty day moving average price is $37.27 and its 200-day moving average price is $38.99.

CareTrust REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, October 15th. Stockholders of record on Wednesday, September 30th were paid a $0.39 dividend. This represents a $1.56 annualized dividend and a dividend yield of 4.0%. The ex-dividend date was Wednesday, September 30th. CareTrust REIT’s dividend payout ratio is 98.11%.

Hedge Funds Weigh In On CareTrust REIT

Several institutional investors and hedge funds have recently bought and sold shares of the stock. BlackRock Inc. bought a new stake in CareTrust REIT during the second quarter valued at about $1,643,290,000. Deutsche Bank AG bought a new position in shares of CareTrust REIT in the second quarter worth about $143,963,000. Dimensional Fund Advisors LP lifted its position in shares of CareTrust REIT by 1.9% during the 1st quarter. Dimensional Fund Advisors LP now owns 3,333,252 shares of the company’s stock valued at $122,164,000 after buying an additional 61,417 shares in the last quarter. Bank of New York Mellon Corp purchased a new position in shares of CareTrust REIT during the 2nd quarter valued at about $102,162,000. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of CareTrust REIT by 35,170.9% during the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,411,896 shares of the company’s stock valued at $56,970,000 after buying an additional 1,407,893 shares in the last quarter. 87.77% of the stock is currently owned by hedge funds and other institutional investors.

Key Stories Impacting CareTrust REIT

Here are the key news stories impacting CareTrust REIT this week:

• Positive Sentiment: Huntington projects EPS of $2.05 for FY2026, rising to $2.31 in FY2027 and $2.43 in FY2028, and maintains a $44 target. Against the provided $38.81 opening price, that target implies roughly 13% potential appreciation. CareTrust REIT analyst estimates
• Positive Sentiment: A separate report headline puts the brokerage consensus target at $43.64, also above the provided opening price. CareTrust REIT consensus target price
• Neutral Sentiment: Huntington’s FY2026 EPS estimate of $2.05 is slightly below the cited analyst consensus of $2.07. The available reports do not describe a new business development or a change in rating, so the estimates may offer limited fresh direction for the shares.

CareTrust REIT Company Profile

CareTrust REIT, Inc is a real estate investment trust that owns and invests in healthcare-related properties, with a focus on skilled nursing facilities and senior housing. Its portfolio also includes assisted living and other properties that serve older adults and people requiring healthcare services.

The company primarily works with healthcare operators through long-term property leases and other real estate investments. CareTrust’s properties are located across the United States, and the company has expanded its investments into the United Kingdom.

CareTrust became an independent publicly traded company in 2014 after separating from The Ensign Group, a healthcare services provider.